Company profile
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
11 Jul 22
DFAN14A
Additional proxy materials by non-management
24 Jun 22
DFAN14A
Additional proxy materials by non-management
21 Jun 22
DFAN14A
Additional proxy materials by non-management
17 Jun 22
DFAN14A
Additional proxy materials by non-management
13 Jun 22
DFAN14A
Additional proxy materials by non-management
7 Jun 22
DEFC14A
Proxy in contested solicitation
6 Jun 22
PRRN14A
Revised preliminary proxy statement filed by non-management
24 May 22
PREC14A
Preliminary proxy with contested solicitation
18 Apr 22
Latest ownership filings
SC 13G
Outlook Therapeutics, Inc.
28 Mar 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
4
BALAJI VENKATARAMAN
9 Feb 24
SC 13D/A
Jasper Therapeutics, Inc.
9 Feb 24
SC 13G/A
Edesa Biotech, Inc.
29 Jan 24
13F-HR
Quarterly holdings report by institutional manager
13 Nov 23
4
BALAJI VENKATARAMAN
4 Oct 23
4
BALAJI VENKATARAMAN
17 Aug 23
SC 13D/A
ALIMERA SCIENCES INC
16 Aug 23
13F-HR
Quarterly holdings report by institutional manager
11 Aug 23